The UK government is set to introduce a revolutionary blood test capable of detecting signs of the 12 most common cancers before any symptoms appear.
Health Secretary Wes Streeting, a cancer survivor himself, announced plans for the government-funded ‘universal’ blood screening, which could be implemented within five years.
This test, similar to the PCR tests used during the pandemic, is expected to significantly boost survival rates and save numerous lives annually.
Streeting highlighted that just a few drops of blood could reveal if a patient has lung, breast, or bladder cancer, potentially eliminating long waits for tests and scans. The test, which will cost £120 (approximately $157) per patient, will screen for lung, breast, prostate, pancreatic, colorectal, ovarian, liver, brain, oesophageal, bladder, bone and soft tissue sarcoma, and gastric cancers.
The initiative, backed by £2.5 million ($3.28 million) from the UK government through the National Institute for Health and Care Research, has the potential to be a “game-changer.” A startup, Xgenera, has been established by scientists to assist with the rollout, which they claim could save millions of lives.
Currently, more than 320,000 people in the UK are diagnosed with prostate, breast, bowel, and lung cancers each year. Experts also noted that during the first year of the pandemic, nearly 40,000 cancer cases went undiagnosed. At present, screening programs remain one of the most effective methods for early cancer detection.
